Kathleen Ruchalski, MD was selected to participate in the 2021-2022 FDA-AACR Oncology Educational Fellowship by the American Association for Cancer Research (AACR).
The FDA-AACR oncology educational fellowship is designed to promote scientific progress through exchange of scientific knowledge in oncology education, collaborative learning, and research. Through targeted educational activities and interactions with experts from the AACR and the FDA Oncology Center of Excellence, FDA-AACR Oncology Educational Fellows will increase their familiarity and experience with oncology drug development and the regulatory review process.
